Literature DB >> 7486933

Bactericidal and morphological effects of amoxicillin on Helicobacter pylori.

V Berry1, K Jennings, G Woodnutt.   

Abstract

The growth kinetics of Helicobacter pylori after it has been exposed to amoxicillin have been investigated in conjunction with studies of cell morphology. A potent bactericidal effect was observed at concentrations 10-fold higher than the MIC, but this was accompanied by an increase in the residual numbers of coccoid forms observed. In the presence of 10 micrograms of amoxicillin per ml, these forms could be detected as rapidly as 6 h after exposure to the antibiotic. Although the clinical relevance of coccoid forms remains unknown, such forms should be considered when potential anti-Helicobacter agents are tested in vitro.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7486933      PMCID: PMC162840          DOI: 10.1128/AAC.39.8.1859

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  5 in total

1.  Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori.

Authors:  T Iwahi; H Satoh; M Nakao; T Iwasaki; T Yamazaki; K Kubo; T Tamura; A Imada
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

2.  [Polymorphism in Helicobacter pylori--a key function in recurrence of infection?].

Authors:  G Bode; P Malfertheiner; A Ströhle; F Mauch; M Nilius; H Ditschuneit
Journal:  Med Klin (Munich)       Date:  1992-04-15

3.  Survival of Helicobacter pylori in water and saline.

Authors:  A P West; M R Millar; D S Tompkins
Journal:  J Clin Pathol       Date:  1990-07       Impact factor: 3.411

4.  The coccoid forms of Helicobacter pylori. Criteria for their viability.

Authors:  G Bode; F Mauch; P Malfertheiner
Journal:  Epidemiol Infect       Date:  1993-12       Impact factor: 2.451

5.  Characterization of the morphologic conversion of Helicobacter pylori from bacillary to coccoid forms.

Authors:  C E Catrenich; K M Makin
Journal:  Scand J Gastroenterol Suppl       Date:  1991
  5 in total
  38 in total

1.  In vitro anti-Helicobacter pylori activities of new rifamycin derivatives, KRM-1648 and KRM-1657.

Authors:  J K Akada; M Shirai; K Fujii; K Okita; T Nakazawa
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  Morphological effects of miconazole on Helicobacter pylori.

Authors:  G von Recklinghausen; E N Schmid; A Vollmer; R Ansorg
Journal:  Antimicrob Agents Chemother       Date:  1998-03       Impact factor: 5.191

3.  Changes in Helicobacter pylori ultrastructure and antigens during conversion from the bacillary to the coccoid form.

Authors:  M Benaissa; P Babin; N Quellard; L Pezennec; Y Cenatiempo; J L Fauchère
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

4.  Competition of various beta-lactam antibiotics for the major penicillin-binding proteins of Helicobacter pylori: antibacterial activity and effects on bacterial morphology.

Authors:  C R DeLoney; N L Schiller
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

5.  Risk of development of in vitro resistance to amoxicillin, clarithromycin, and metronidazole in Helicobacter pylori.

Authors:  M Sörberg; H Hanberger; M Nilsson; A Björkman; L E Nilsson
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

6.  High-dose dual therapy is effective as first-line treatment for Helicobacter pylori infection.

Authors:  Kadir Öztürk; Ömer Kurt; Gürkan Çelebi; Hakan Şarlak; Muhammed Fatih Karakaya; Hakan Demirci; Ali Kılınç; Ahmet Uygun
Journal:  Turk J Gastroenterol       Date:  2020-03       Impact factor: 1.852

7.  Comparison of the nucleic acids of helical and coccoid forms of Helicobacter pylori.

Authors:  S Narikawa; S Kawai; H Aoshima; O Kawamata; R Kawaguchi; K Hikiji; M Kato; S Iino; Y Mizushima
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

8.  Anti-Helicobacter pylori effect of mucoadhesive nanoparticles bearing amoxicillin in experimental gerbils model.

Authors:  R B Umamaheshwari; Suman Ramteke; Narendra Kumar Jain
Journal:  AAPS PharmSciTech       Date:  2004-04-07       Impact factor: 3.246

9.  Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB.

Authors:  M H Coconnier; V Lievin; E Hemery; A L Servin
Journal:  Appl Environ Microbiol       Date:  1998-11       Impact factor: 4.792

10.  Urease activity and urea gene sequencing of coccoid forms of H. pylori induced by different factors.

Authors:  Fusun Can; Ceren Karahan; Istar Dolapci; Muge Demirbilek; Alper Tekeli; Hande Arslan
Journal:  Curr Microbiol       Date:  2008-01-01       Impact factor: 2.188

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.